每經AI快訊，國(guo)邦醫藥(yao)（SH 605507，收盤價：16.22元）4月(yue)(yue)18日(ri)晚(wan)間發布公(gong)(gong)(gong)(gong)(gong)告稱(cheng)，截(jie)至本(ben)(ben)公(gong)(gong)(gong)(gong)(gong)告披露(lu)日(ri)，股(gu)(gu)(gu)(gu)(gu)(gu)東上饒市(shi)浙民(min)(min)投(tou)(tou)(tou)恒(heng)華(hua)(hua)創業投(tou)(tou)(tou)資(zi)合(he)伙企業（有(you)限(xian)(xian)合(he)伙）、浙江(jiang)絲路產業投(tou)(tou)(tou)資(zi)基金(jin)合(he)伙企業（有(you)限(xian)(xian)合(he)伙）分別持(chi)有(you)國(guo)邦醫藥(yao)集團股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)無(wu)限(xian)(xian)售(shou)(shou)流通(tong)(tong)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)約1766萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)、約1340萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)3.16%、2.4%。浙民(min)(min)投(tou)(tou)(tou)恒(heng)華(hua)(hua)、絲路基金(jin)為一致行動(dong)人，合(he)計持(chi)有(you)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)無(wu)限(xian)(xian)售(shou)(shou)流通(tong)(tong)股(gu)(gu)(gu)(gu)(gu)(gu)約3106萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)5.56%。相(xiang)關股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)已于2023年(nian)2月(yue)(yue)2日(ri)解除限(xian)(xian)售(shou)(shou)并上市(shi)流通(tong)(tong)。股(gu)(gu)(gu)(gu)(gu)(gu)東浙民(min)(min)投(tou)(tou)(tou)恒(heng)華(hua)(hua)、絲路基金(jin)因自(zi)身資(zi)金(jin)需求，計劃通(tong)(tong)過(guo)(guo)集中競(jing)價及(ji)大宗(zong)(zong)交易(yi)(yi)方式(shi)減(jian)持(chi)其持(chi)有(you)的(de)(de)(de)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)合(he)計不(bu)(bu)(bu)超(chao)過(guo)(guo)約1676萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，減(jian)持(chi)比(bi)例不(bu)(bu)(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)3%。其中：擬(ni)通(tong)(tong)過(guo)(guo)集中競(jing)價方式(shi)進(jin)行減(jian)持(chi)的(de)(de)(de)，將(jiang)于本(ben)(ben)公(gong)(gong)(gong)(gong)(gong)告披露(lu)之(zhi)(zhi)日(ri)起15個交易(yi)(yi)日(ri)后(hou)的(de)(de)(de)3個月(yue)(yue)內減(jian)持(chi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)不(bu)(bu)(bu)超(chao)過(guo)(guo)約559萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，即(ji)減(jian)持(chi)不(bu)(bu)(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)1%，且在任(ren)意連(lian)續90日(ri)內，合(he)計減(jian)持(chi)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)總(zong)(zong)(zong)(zong)(zong)數不(bu)(bu)(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)1%；擬(ni)通(tong)(tong)過(guo)(guo)大宗(zong)(zong)交易(yi)(yi)方式(shi)進(jin)行減(jian)持(chi)的(de)(de)(de)，將(jiang)于本(ben)(ben)公(gong)(gong)(gong)(gong)(gong)告披露(lu)之(zhi)(zhi)日(ri)起3個交易(yi)(yi)日(ri)后(hou)的(de)(de)(de)3個月(yue)(yue)內減(jian)持(chi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)不(bu)(bu)(bu)超(chao)過(guo)(guo)約1118萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，即(ji)減(jian)持(chi)不(bu)(bu)(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)2%，且在任(ren)意連(lian)續90日(ri)內，合(he)計減(jian)持(chi)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)總(zong)(zong)(zong)(zong)(zong)數不(bu)(bu)(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的(de)(de)(de)2%。

2023年1至(zhi)12月份，國邦醫(yi)藥的營業收入構成(cheng)為：醫(yi)藥板(ban)塊占比65.15%，動物保健品板(ban)塊占比34.3%，其他占比0.13%。

國邦醫藥的(de)董事長是(shi)邱家軍(jun)，男，59歲(sui)，學(xue)歷背(bei)景(jing)為(wei)博(bo)士(shi)；總裁是(shi)廖仕學(xue)，男，49歲(sui)，學(xue)歷背(bei)景(jing)為(wei)碩士(shi)。

截至(zhi)發稿，國邦醫(yi)藥市值為91億元(yuan)。

道達號（daoda1997）“個股趨勢(shi)”提醒：
1. 國邦醫藥近30日內北向資金持股量減少59.83萬股，占流通股比例減少0.19%；
2. 近30日內無機構對國邦醫藥進行調研；
3. 國(guo)邦醫藥上次發(fa)布減持公告是2024年03月13日，第二個交易日下跌0.26%，國(guo)邦醫藥近一年共發(fa)布9次減持類(lei)公告。

每(mei)經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲明：本文內容與數據僅供參考，不(bu)構(gou)成(cheng)投資(zi)建議，使用前請(qing)核實。據此操(cao)作，風險自擔。